havrix monodose vaccine, hepatitis a vaccine (inactivated, adsorbed) susp for inj 1440elu/ml
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - hepatitis a, virus, inactivated, elisa - suspension for injection in pre-filled syringe - hepatitis a virus (inactivated) 1440 elisa unit/dose - vaccines
havrix junior monodose vaccine, hepatitis a vaccine(inactivated absorbed) susp for inj 720elu/0.5ml
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - hepatitis a, virus, inactivated, elisa - suspension for injection in pre-filled syringe - hepatitis a virus (inactivated) 720 elisa unit/dose - vaccines
infanrix-ipv+hib powder and suspension for suspension for injection. diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)
glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis filamentous, haemagglutinin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate, tetanus toxoid - powder and suspension for suspension for injection - pertactin 8 µg pertussis filamentous haemagglutinin 25 µg pertussis toxoid 25 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu/0.5ml poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu/0.5ml poliovirus (inactivated) type 3 (saukett strain) 32 dagu/0.5ml diphtheria toxoid haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg tetanus toxoid - vaccines
inactivated mycoplasma hyopneumoniae strain j
intervet australia pty limited - inactivated mycoplasma hyopneumoniae strain j - unknown - inactivated mycoplasma hyopneumoniae strain j vaccine - general active 0.0 - immunotherapy
btvpur alsap 2-4
mérial - bluetongue-virus serotype-2 antigen, bluetongue-virus serotype-4 antigen - bluetongue virus, inactivated viral vaccines, immunologicals for ovidae - sheep - active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 2 and 4.
poulvac newcastle ik vaccine (inactivated)
zoetis australia pty ltd - inactivated newcastle disease virus antigen - parenteral liquid/solution/suspension - inactivated newcastle disease virus antigen vaccine-viral active 0.0 eid/50 - immunotherapy - poultry - see label | chicken - newcastle disease
btvpur
boehringer ingelheim vetmedica gmbh - bluetongue-virus serotype-1 antigen, bluetongue virus serotype 8 antigen - immunologicals - sheep; cattle - sheepactive immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/ or 8 (combination of maximum 2 serotypes), active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1,2, 4 and/ or 8 (combination of maximum 2 serotypes), active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).cattleactive immunisation of cattle to prevent viraemia caused by bluetongue virus serotype 1, 2, 4 and/ or 8, and to reduce clinical signs caused by bluetongue virus serotypes when observed in this species: serotype 1, 4 and / or 8 (combination of maximum 2 serotypes).active immunisation of cattle to prevent viraemia caused by bluetongue virus serotype 1, 2, 4 and/ or 8, and to reduce clinical signs caused by bluetongue virus serotypes when observed in this species: serotype 1, 4 and / or 8 (combination of maximum 2 serotypes).active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 1, 2, 4 and/or 8 (combination of maximum 2 serotypes).
coxevac
ceva santé animale - inactivated coxiella burnetii vaccine, strain nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus., onset of immunity: not established., duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta., onset of immunity: not established., duration of immunity: one year after completion of the primary vaccination course.
eravac
laboratorios hipra, s.a. - inactivated rabbit haemorrhagic disease type 2 virus (rhdv2), strainv-1037 - inactivated viral vaccines - rabbits - for active immunisation of rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (rhdv2)
suvaxyn circo+mh rtu
zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - inactivated viral and inactivated bacterial vaccines - pigs - for active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with pcv2.for active immunisation of pigs over the age of 3 weeks against mycoplasma hyopneumoniae to reduce lung lesions caused by infection with m. hyopneumoniae.